klow 80mg – Corix Labs KLOW (80MG UNIT) - Peptora

First-in-human biomarker-driven phase I trial of the potent and selective glutaminase-1 (GLS1) inhibitor IACS-6274 (IPN60090) in patients with molecularly selected advanced solid tumors

It has also been shown to increase the proliferation of liver cells Kupffer cells, which phagocytose pathogens, bacteria and other foreign material from the blood (6)

All our injectable nutrients are manufactured in Australia under GMP (good manufacturing practice) guidelines, or strict sterile compounding standards to ensure batch stability and auditing capability

Besides the discovery of new protein binding sites and the development of new molecules, research should also focus on ways to reactivate herbicides lost to resistance or reverse herbicide resistance in problematic weeds